# Nuclide record oslo-radium-hospital (institution). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/institutions/oslo-radium-hospital/>
  a schema:MedicalOrganization ;
  nuclide:kind "institution" ;
  schema:identifier "oslo-radium-hospital" ;
  schema:name "Oslo University Hospital, The Norwegian Radium Hospital"@en ;
  schema:alternateName "Radiumhospitalet"@en, "Institute for Cancer Research Oslo"@en, "OUS"@en ;
  schema:description "Norway's national cancer hospital and research institute, where the alpha emitter radium-223 (Xofigo) and Photocure's bladder imaging agent were born."@en ;
  schema:url <https://nuclide.cc/institutions/oslo-radium-hospital/>, <https://www.ous-research.no/institute/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:citation <https://www.ous-research.no/institute/>, <https://www.oslo-universitetssykehus.no>, <https://oslocancercluster.no> ;
  schema:addressCountry "NO" ;
  schema:addressLocality "Oslo" ;
  schema:latitude "59.933"^^xsd:decimal ;
  schema:longitude "10.66"^^xsd:decimal ;
  nuclide:related <https://nuclide.cc/isotopes/ra-223/> ;
  nuclide:indications <https://nuclide.cc/indications/prostate/> ;
  nuclide:technologies <https://nuclide.cc/technologies/targeted-alpha-therapy/>, <https://nuclide.cc/technologies/radioligand-therapy/> ;
  nuclide:companies <https://nuclide.cc/companies/bayer/> ;
  nuclide:institutions <https://nuclide.cc/institutions/karolinska/> ;
  nuclide:terms <https://nuclide.cc/terms/alpha-vs-beta/> .